SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease
Angelika Wagner(Medical University of Vienna), Ursula Wiedermann(Medical University of Vienna), Bernhard Kratzer(Medical University of Vienna), Erika Garner‐Spitzer(Medical University of Vienna), Lukas Weseslindtner(Medical University of Vienna), Maria Jonah Orola(Medical University of Vienna), Winfried F. Pickl(Medical University of Vienna), Anna Ohradanova‐Repic(Medical University of Vienna), Maximilian Kutschera(Medical University of Vienna), Gábor Tajti(Medical University of Vienna), Gottfried Novacek(Medical University of Vienna), Elena Tomosel(Medical University of Vienna), Anna‐Margarita Schötta(Medical University of Vienna), Christoph Zielinski(Vienna General Hospital), Laura Gebetsberger(Medical University of Vienna), Selma Tobudic(Medical University of Vienna), Andrea Wessely(Medical University of Vienna), Hannes Stockinger(Medical University of Vienna), Ines Zwazl(Medical University of Vienna), Walter Reinisch(Medical University of Vienna), Michael Kundi(Medical University of Vienna)
Cited by 64
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
|Gastroenterology|2013|938
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566
Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.
|PubMed|2012|531
EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses
|Reviews on Environmental Health|2016|496